Epidiolex — Cigna
Dravet syndrome
Initial criteria
- Patient is age ≥ 1 year; AND
- Patient meets ONE of the following (a or b): a) Patient has tried or is concomitantly receiving at least two other antiseizure medications; OR b) Patient has tried or is concomitantly receiving one of Fintepla, Diacomit, or clobazam; AND
- The medication is prescribed by or in consultation with a neurologist
Reauthorization criteria
- Patient is currently receiving Epidiolex and is responding to therapy (e.g., reduced seizure severity, frequency, and/or duration) as determined by the prescriber
Approval duration
1 year